NRC HEALTH (NRC) Fundamental Analysis & Valuation
NASDAQ:NRC • US6373722023
Current stock price
17.41 USD
+0.95 (+5.77%)
At close:
17.41 USD
0 (0%)
After Hours:
This NRC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NRC Profitability Analysis
1.1 Basic Checks
- NRC had positive earnings in the past year.
- NRC had a positive operating cash flow in the past year.
- NRC had positive earnings in each of the past 5 years.
- In the past 5 years NRC always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 8.37%, NRC belongs to the best of the industry, outperforming 93.00% of the companies in the same industry.
- NRC's Return On Equity of 80.72% is amongst the best of the industry. NRC outperforms 98.00% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 16.19%, NRC belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for NRC is significantly above the industry average of 8.40%.
- The 3 year average ROIC (24.89%) for NRC is well above the current ROIC(16.19%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.37% | ||
| ROE | 80.72% | ||
| ROIC | 16.19% |
ROA(3y)17.45%
ROA(5y)20.09%
ROE(3y)74.39%
ROE(5y)62.24%
ROIC(3y)24.89%
ROIC(5y)29.78%
1.3 Margins
- NRC has a Profit Margin of 8.22%. This is amongst the best in the industry. NRC outperforms 90.00% of its industry peers.
- In the last couple of years the Profit Margin of NRC has declined.
- Looking at the Operating Margin, with a value of 16.45%, NRC belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
- NRC's Operating Margin has declined in the last couple of years.
- With an excellent Gross Margin value of 61.88%, NRC belongs to the best of the industry, outperforming 83.00% of the companies in the same industry.
- In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.45% | ||
| PM (TTM) | 8.22% | ||
| GM | 61.88% |
OM growth 3Y-25.58%
OM growth 5Y-12.28%
PM growth 3Y-26.82%
PM growth 5Y-21.69%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
2. NRC Health Analysis
2.1 Basic Checks
- NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- NRC has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, NRC has less shares outstanding
- Compared to 1 year ago, NRC has a worse debt to assets ratio.
2.2 Solvency
- NRC has an Altman-Z score of 3.10. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of NRC (3.10) is better than 69.00% of its industry peers.
- NRC has a debt to FCF ratio of 5.02. This is a neutral value as NRC would need 5.02 years to pay back of all of its debts.
- NRC has a Debt to FCF ratio (5.02) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 5.36 is on the high side and indicates that NRC has dependencies on debt financing.
- NRC's Debt to Equity ratio of 5.36 is on the low side compared to the rest of the industry. NRC is outperformed by 79.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.36 | ||
| Debt/FCF | 5.02 | ||
| Altman-Z | 3.1 |
ROIC/WACC1.85
WACC8.76%
2.3 Liquidity
- NRC has a Current Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
- NRC's Current ratio of 0.55 is on the low side compared to the rest of the industry. NRC is outperformed by 90.00% of its industry peers.
- NRC has a Quick Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.55, NRC is not doing good in the industry: 86.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.55 |
3. NRC Growth Analysis
3.1 Past
- NRC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
- The Earnings Per Share has been growing slightly by 3.24% on average over the past years.
- NRC shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
- Measured over the past years, NRC shows a small growth in Revenue. The Revenue has been growing by 4.42% on average per year.
EPS 1Y (TTM)-1.19%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%N/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%3.72%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. NRC Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 13.93, NRC is valued correctly.
- Based on the Price/Earnings ratio, NRC is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
- NRC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.93 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as NRC.
- NRC's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.16 | ||
| EV/EBITDA | 14.87 |
4.3 Compensation for Growth
- NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.3
EPS Next 2YN/A
EPS Next 3YN/A
5. NRC Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 3.87%, NRC has a reasonable but not impressive dividend return.
- NRC's Dividend Yield is rather good when compared to the industry average which is at 0.46. NRC pays more dividend than 99.00% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, NRC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.87% |
5.2 History
- The dividend of NRC has a limited annual growth rate of 2.80%.
- NRC has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of NRC decreased recently.
Dividend Growth(5Y)2.8%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- NRC pays out 97.21% of its income as dividend. This is not a sustainable payout ratio.
- NRC's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP97.21%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Fundamentals: All Metrics, Ratios and Statistics
17.41
+0.95 (+5.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth86.96
Earnings (Last)04-28 2026-04-28/amc
Earnings (Next)07-27 2026-07-27
Inst Owners48.16%
Inst Owner Change0%
Ins Owners10.65%
Ins Owner Change1.04%
Market Cap396.08M
Revenue(TTM)148.58M
Net Income(TTM)11.29M
Analysts45
Price TargetN/A
Short Float %3.61%
Short Ratio4.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.87% |
Yearly Dividend0.48
Dividend Growth(5Y)2.8%
DP97.21%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-27 2026-03-27 (0.16)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.93 | ||
| Fwd PE | N/A | ||
| P/S | 2.88 | ||
| P/FCF | 25.16 | ||
| P/OCF | 14.97 | ||
| P/B | 28.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.87 |
EPS(TTM)1.25
EY7.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.69
FCFY3.97%
OCF(TTM)1.16
OCFY6.68%
SpS6.04
BVpS0.61
TBVpS-2.39
PEG (NY)N/A
PEG (5Y)4.3
Graham Number4.15877 (-76.11%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.37% | ||
| ROE | 80.72% | ||
| ROCE | 23% | ||
| ROIC | 16.19% | ||
| ROICexc | 16.91% | ||
| ROICexgc | 61.81% | ||
| OM | 16.45% | ||
| PM (TTM) | 8.22% | ||
| GM | 61.88% | ||
| FCFM | 11.46% |
ROA(3y)17.45%
ROA(5y)20.09%
ROE(3y)74.39%
ROE(5y)62.24%
ROIC(3y)24.89%
ROIC(5y)29.78%
ROICexc(3y)26.44%
ROICexc(5y)39.02%
ROICexgc(3y)112.69%
ROICexgc(5y)N/A
ROCE(3y)35.36%
ROCE(5y)42.3%
ROICexgc growth 3Y-49.45%
ROICexgc growth 5Y-29.62%
ROICexc growth 3Y-34.11%
ROICexc growth 5Y-17.54%
OM growth 3Y-25.58%
OM growth 5Y-12.28%
PM growth 3Y-26.82%
PM growth 5Y-21.69%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.36 | ||
| Debt/FCF | 5.02 | ||
| Debt/EBITDA | 2.48 | ||
| Cap/Depr | 140.43% | ||
| Cap/Sales | 7.79% | ||
| Interest Coverage | 5.04 | ||
| Cash Conversion | 87.52% | ||
| Profit Quality | 139.41% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.55 | ||
| Altman-Z | 3.1 |
F-Score6
WACC8.76%
ROIC/WACC1.85
Cap/Depr(3y)221.48%
Cap/Depr(5y)187.46%
Cap/Sales(3y)9.74%
Cap/Sales(5y)7.88%
Profit Quality(3y)96.31%
Profit Quality(5y)96.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%3.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.67%
EBIT growth 3Y-27.98%
EBIT growth 5Y-11.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3Y-15.86%
FCF growth 5Y-15.55%
OCF growth 1Y-23.61%
OCF growth 3Y-9.99%
OCF growth 5Y-8.23%
NRC HEALTH / NRC Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NRC HEALTH (NRC) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NRC.
Can you provide the valuation status for NRC HEALTH?
ChartMill assigns a valuation rating of 3 / 10 to NRC HEALTH (NRC). This can be considered as Overvalued.
How profitable is NRC HEALTH (NRC) stock?
NRC HEALTH (NRC) has a profitability rating of 8 / 10.
Can you provide the dividend sustainability for NRC stock?
The dividend rating of NRC HEALTH (NRC) is 5 / 10 and the dividend payout ratio is 97.21%.